Follow
Ebenezer Tumban
Ebenezer Tumban
Verified email at ttu.edu
Title
Cited by
Cited by
Year
A current update on human papillomavirus-associated head and neck cancers
E Tumban
Viruses 11 (10), 922, 2019
2042019
Gardasil-9: A global survey of projected efficacy
L Zhai, E Tumban
Antiviral research 130, 101-109, 2016
1732016
A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2
E Tumban, J Peabody, DS Peabody, B Chackerian
PloS one 6 (8), e23310, 2011
1412011
VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus
E Tumban, J Peabody, M Tyler, DS Peabody, B Chackerian
PloS one 7 (11), e49751, 2012
1072012
Lead SARS-CoV-2 candidate vaccines: expectations from phase III trials and recommendations post-vaccine approval
E Tumban
Viruses 13 (1), 54, 2020
982020
A universal virus-like particle-based vaccine for human papillomavirus: longevity of protection and role of endogenous and exogenous adjuvants
E Tumban, J Peabody, DS Peabody, B Chackerian
Vaccine 31 (41), 4647-4654, 2013
812013
Optimized formulation of a thermostable spray-dried virus-like particle vaccine against human papillomavirus
S Saboo, E Tumban, J Peabody, D Wafula, DS Peabody, B Chackerian, ...
Molecular pharmaceutics 13 (5), 1646-1655, 2016
712016
Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2
E Tumban, P Muttil, CAA Escobar, J Peabody, D Wafula, DS Peabody, ...
Vaccine 33 (29), 3346-3353, 2015
712015
Secondary structure of dengue virus type 4 3′ untranslated region: impact of deletion and substitution mutations
TA Romero, E Tumban, J Jun, WB Lott, KA Hanley
Journal of general virology 87 (11), 3291-3296, 2006
602006
The use of hybrid virus‐like particles to enhance the immunogenicity of a broadly protective HPV vaccine
M Tyler, E Tumban, DS Peabody, B Chackerian
Biotechnology and bioengineering 111 (12), 2398-2406, 2014
552014
Oral immunization with bacteriophage MS2-L2 VLPs protects against oral and genital infection with multiple HPV types associated with head & neck cancers and cervical cancer
L Zhai, R Yadav, NK Kunda, D Anderson, E Bruckner, EK Miller, R Basu, ...
Antiviral research 166, 56-65, 2019
542019
A novel candidate HPV vaccine: MS2 phage VLP displaying a tandem HPV L2 peptide offers similar protection in mice to Gardasil-9
L Zhai, J Peabody, YYS Pang, J Schiller, B Chackerian, E Tumban
Antiviral research 147, 116-123, 2017
542017
Virus-like particle-based L2 vaccines against HPVs: Where are we today?
R Yadav, L Zhai, E Tumban
Viruses 12 (1), 18, 2019
502019
Zika virus on a spreading spree: what we now know that was unknown in the 1950’s
R Basu, E Tumban
Virology journal 13, 1-9, 2016
482016
Second-generation prophylactic HPV vaccines: successes and challenges
M Tyler, E Tumban, B Chackerian
Expert review of vaccines 13 (2), 247-255, 2014
452014
Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells
R Basu, L Zhai, A Contreras, E Tumban
Vaccine 36 (10), 1256-1264, 2018
442018
Immunization with a consensus epitope from human papillomavirus L2 induces antibodies that are broadly neutralizing
M Tyler, E Tumban, A Dziduszko, MA Ozbun, DS Peabody, B Chackerian
Vaccine 32 (34), 4267-4274, 2014
412014
Characterization of a spray-dried candidate HPV L2-VLP vaccine stored for multiple years at room temperature
J Peabody, P Muttil, B Chackerian, E Tumban
Papillomavirus Research 3, 116-120, 2017
292017
Evaluation of the thermal stability and the protective efficacy of spray-dried HPV vaccine, Gardasil® 9
NK Kunda, J Peabody, L Zhai, DN Price, B Chackerian, E Tumban, ...
Human Vaccines & Immunotherapeutics, 2019
242019
Aerosol delivery of virus-like particles to the genital tract induces local and systemic antibody responses
Z Hunter, E Tumban, A Dziduszko, B Chackerian
Vaccine 29 (28), 4584-4592, 2011
222011
The system can't perform the operation now. Try again later.
Articles 1–20